Clinical Trial: Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Bladder Cancer
Study Type: OBSERVATIONAL
Official Title: Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Brief Summary:
BCDx is a urine-based multi-omic assay for early cancer recurrence detection in patients with a history of bladder cancer.This prospective, blinded study evaluates its efficacy in detecting recurrent NMIBC, offering a noninvasive monitoring solution.
Read more